Okara, soybean residue, prevents obesity in a diet-induced murine obesity model

Bioscience, Biotechnology and Biochemistry

Volumn 71, Issue 3, 2007, Pages 720-727

  Matsumoto, Kenji ^a   Watanabe, Yutaka ^a   Yokoyama, Shin Ichiro ^a  

^a Gifu Prefectural Research Institute for Bioengineering   (Japan)

Author keywords

Hepatocyte steatosis; Lipid disorder; Obesity; Okara; Soybean residue

Indexed keywords

HEPATOCYTE STEATOSIS; LIPID DISORDER; OBESITY; OKARA; SOYBEAN RESIDUE;

AGRICULTURAL WASTES; CHOLESTEROL; FATTY ACIDS; LIPIDS; NUTRITION; OILS AND FATS; TISSUE;

PULP;

CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYTOCHROME P450 7A1, MOUSE; FATTY ACID; FATTY ACID SYNTHASE; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OKARA, GLYCINE MAX; POLYSACCHARIDE; UNCLASSIFIED DRUG; VEGETABLE PROTEIN;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; CHEMISTRY; DIET; DRUG EFFECT; FATTY LIVER; GENE EXPRESSION REGULATION; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; MALE; METABOLISM; MOUSE; MOUSE MUTANT; OBESITY; PATHOLOGY; SOYBEAN; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHOLESTEROL, LDL; DIET; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; GENE EXPRESSION REGULATION; LEPTIN; LIVER; MALE; MICE; MICE, INBRED ICR; MICE, OBESE; OBESITY; PLANT PROTEINS; POLYSACCHARIDES; SOY FOODS; SOYBEANS;

FATTY ACIDS; PLANT RESIDUES; STEROLS;

GLYCINE MAX; MURINAE; MUS;

EID: 33947576447     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.60563     Document Type: Article

References (39)

1. Bhathena, S. J., and Velasquez, M. T., Beneficial role of dietary phytoestrogens in obesity and diabetes. Am. J. Clin. Nutr., 76, 1191-1201 (2002).
2. Merritt, J. C., Metabolic syndrome: soybean foods and serum lipids. J. Natl. Med. Assoc., 96, 1032-1041 (2004).
3. Banz, W. J., Davis, J., Peterson, R., and Iqbal, M. J., Gene expression and adiposity are modified by soy protein in male Zucker diabetic fatty rats. Obes. Res., 12, 1907-1913 (2004).
4. Tovar, A. R., Torre-Villalvazo, I., Ochoa, M., Elias, A. L., Ortiz, V., Aguilar-Salinas, C. A., and Torres, N., Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats. J. Lipid Res., 46, 1823-1832 (2005).
5. Torres, N., Torre-Villalvazo, I., and Tovar, A. R., Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J. Nutr. Biochem., 17, 365-373 (2006).
6. O' Toole, D. K., Characteristics and use of okara, the soybean residue from soy milk production - a review. J. Agric. Food Chem., 47, 363-371 (1999).
7. Matsuo, M., In vivo antioxidant activity of Okara Koji, a fermented okara, by Aspergillus oryzae. Biosci. Biotechnol. Biochem., 61, 1968-1972 (1997).
8. Jiang, W. Z., Kitamura, Y., and Li, B., Improving acidogenic performance in anaerobic degradation of solid organic waste using a rotational drum fermentation system. Biores. Technol., 96, 1537-1543 (2005).
9. Mizumoto, S., Hirai, M., and Shoda, M., Production of lipopeptide antibiotic iturin A using soybean curd residue cultivated with Bacillus subtilis in solid-state fermentation. Appl. Microbiol. Biotechnol., 72, 869-875 (2006).
10. Quitain, A. T., Oro, K., Katoh, S., and Moriyoshi, T., Recovery of oil components of okara by ethanol-modified supercritical carbon dioxide extraction. Biores. Technol., 97, 1509-1514 (2006).
11. Kasai, N., Murata, A., Inui, H., Sakamoto, T., and Kahn, R. I., Enzymatic high digestion of soybean milk residue (okara). J. Agric. Food Chem., 52, 5709-5716 (2004).
12. Visscher, T. L., Kromhout, D., and Seidell, J. C., Long-term and recent time trends in the prevalence of obesity among Dutch men and women. Int. J. Obes. Relat. Metab. Disord., 26, 1218-1224 (2002).
13. Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., and Marks, J. S., Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA, 289, 76-79 (2003).
14. Bendixen, H., Holst, C., Sorensen, T. I., Raben, A., Bartels, E. M., and Astrup, A., Major increase in prevalence of overweight and obesity between 1987 and 2001 among Danish adults. Obes. Res., 12, 1464-1472 (2004).
15. Monteiro, C. A., D'A Benicio, M. H., Conde, W. L., and Popkin, B. M., Shifting obesity trends in Brazil. Eur. J. Clin. Nutr., 54, 342-346 (2000).
16. Salazar-Martinez, E., Allen, B., Fernandez-Ortega, C., Torres-Mejia, G., Galal, O., and Lazcano-Ponce, E., Overweight and obesity status among adolescents from Mexico and Egypt. Arch. Med. Res., 37, 535-542 (2006).
17. Willett, W. C., Dietz, W. H., and Colditz, G. A., Guidelines for healthy weight. N. Engl. J. Med., 341, 427-434 (1999).
18. Fontaine, K. R., Redden, D. T., Wang, C., Westfall, A. O., and Allison, D. B., Years of life lost due to obesity. JAMA, 289, 187-193 (2003).
19. Roberts, S. B., McCrory, M. A., and Saltzman, E., The influence of dietary composition on energy intake and body weight. J. Am. Coll. Nutr., 21, 140S-145S (2002).
20. Slavin, J. L., Dietary fiber and body weight. Nutrition, 21, 411-418 (2005).
21. Council for International Organizations of Medical Sciences, International Guiding Principles for Biomedical Research Involving Animals, Geneva, Switzerland (1985).
22. Matsumoto, K., Kwon, O. Y., Kim, H., and Akao, Y., Expression of rck/p54, a DEAD-box RNA helicase, in gametogenesis and early embryogenesis of mice. Dev. Dyn., 233, 1149-1156 (2005).
23. Matsumoto, K., Hiraiwa, N., Yoshiki, A., Ohnishi, M., and Kusakabe, M., PDGF receptor-alpha deficiency in glomerular mesangial cells of tenascin-C knockout mice. Biochem. Biophys. Res. Commun., 290, 1220-1227 (2002).
24. Haimovici, R., Gantz, D. L., Rumelt, S., Freddo, T. F., and Small, D. M., The lipid composition of drusen, Bruch's membrane, and sclera by hot stage polarizing light microscopy. Invest. Ophthalmol. Vis. Sci., 42, 1592-1599 (2001).
25. Paulauskis, J. D., and Sul, H. S., Cloning and expression of mouse fatty acid synthase and other specific mRNAs. Developmental and hormonal regulation in 3T3-L1 cells. J. Biol. Chem., 263, 7049-7054 (1988).
26. Kleemann, R., and Kooistra, T., HMG-CoA reductase inhibitors: effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol. Curr. Drug Targets Cardiovasc. Haematol. Disord., 5, 441-453 (2005).
27. Cheema, S. K., Cikaluk, D., and Agellon, L. B., Dietary fats modulate the regulatory potential of dietary cholesterol on cholesterol 7α-hydroxylase gene expression. J. Lipid Res., 38, 315-323 (1997).
28. Matsuzawa, Y., White adipose tissue and cardiovascular disease. Best Pract. Res. Clin. Endocrinol. Metab., 19, 637-647 (2005).
29. Koerner, A., Kratzsch, J., and Kiess, W., Adipocytokines: leptin - the classical, resistin - the controversial, adiponectin - the promising, and more to come. Best Pract. Res. Clin. Endocrinol. Metab., 19, 525-546 (2005).
30. Housa, D., Housova, J., Vernerova, Z., and Haluzik, M., Adipocytokines and cancer. Physiol. Res., 55, 233-244 (2006).
31. Zimmet, P., Magliano, D., Matsuzawa, Y., Alberti, G., and Shaw, J., The metabolic syndrome: a global public health problem and a new definition. J. Atheroscler. Thromb., 12, 295-300 (2005).
32. Ascencio, C., Torres, N., Isoard-Acosta, F., Gomez-Perez, F. J., Hernandez-Pando, R., and Tovar, A. R., Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J. Nutr., 134, 522-529 (2004).
33. Tovar, A. R., Torre-Villalvazo, I., Ochoa, M., Elias, A. L., Ortiz, V., Aguilar-Salinas, C. A., and Torres, N., Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats. J. Lipid Res., 46, 1823-1832 (2005).
34. Andersson, M., Ellegard, L., and Andersson, H., Oat bran stimulates bile acid synthesis within 8 h as measured by 7alpha-hydroxy-4-cholesten-3-one. Am. J. Clin. Nutr., 76, 1111-1116 (2002).
35. Chau, C. F., and Huang, Y. L., Effects of the insoluble fiber derived from Passiflora edulis seed on plasma and hepatic lipids and fecal output. Mol. Nutr. Food Res., 49, 786-790 (2005).
36. van Bennekum, A. M., Nguyen, D. V., Schulthess, G., Hauser, H., and Phillips, M. C., Mechanisms of cholesterol-lowering effects of dietary insoluble fibres: relationships with intestinal and hepatic cholesterol parameters. Br. J. Nutr., 94, 331-337 (2005).
37. Afman, L., and Muller, M., Nutrigenomics: from molecular nutrition to prevention of disease. J. Am. Diet. Assoc., 106, 569-576 (2006).
38. Osei-Hyiaman, D., DePetrillo, M., Pacher, P., Liu, J., Radaeva, S., Batkai, S., Harvey-White, J., Mackie, K., Offertaler, L., Wang, L., and Kunos, G., Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest., 115, 1298-1305 (2005).
39. Pietilainen, K. H., Kannisto, K., Korsheninnikova, E., Rissanen, A., Kaprio, J., Ehrenborg, E., Hamsten, A., and Yki-Jarvinen, H., Acquired obesity increases CD68 and TNF-α and decreases adiponectin gene expression in adipose tissue. A study in monozygotic twins. J. Clin. Endocrinol. Metab., 91, 2776-2781 (2006).